Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Adelaide
Clinical trial register · Australia

Clinical Trials in Adelaide, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3379 matching records held by the registry are in this view. Synced 18 Nov 2026, 03:18 UTC
3379
Studies in scope
all four open statuses
1825
Recruiting now
open to new participants
783
Lead sponsors
across recruiting studies
Top sites
Melbourne 18 Camperdown 9 Westmead 9 Parkville 8 Clayton 8
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Eli Lilly and Company23 Janssen Research & Development, LLC16 AstraZeneca13 Novartis Pharmaceuticals13 BioNTech SE13 Hoffmann-La Roche12 Merck Sharp & Dohme LLC12 Monash University9 Bristol-Myers Squibb9 Novo Nordisk A/S9 BeOne Medicines8 Abbott Medical Devices8 Celgene7 Incyte Corporation7 Gilead Sciences7 Boehringer Ingelheim7 AbbVie7 Amgen7 Daiichi Sankyo7 University of Melbourne6 Regeneron Pharmaceuticals6 Pfizer5 Takeda5 Murdoch Childrens Research Institute5 Sanofi5 GlaxoSmithKline4 Genmab4 Genentech, Inc.4 University of Adelaide4 Kirby Institute4 Stichting Hemato-Oncologie voor Volwassenen Nederland4 Otsuka Pharmaceutical Development & Commercialization, Inc.4 ADARx Pharmaceuticals, Inc.4 The University of Queensland3 Acerta Pharma BV3 Biotronik SE & Co. KG3 Edwards Lifesciences3 Genzyme, a Sanofi Company3 K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc3 University of Sydney3 Vaxine Pty Ltd3 Queensland Centre for Gynaecological Cancer3 Akero Therapeutics, Inc3 Olema Oncology, Inc.3 Australasian Gastro-Intestinal Trials Group3 Alnylam Pharmaceuticals3 Central Adelaide Local Health Network Incorporated3 European Myeloma Network B.V.3 Telix Pharmaceuticals (Innovations) Pty Limited3 Peter MacCallum Cancer Centre, Australia3 Alexion Pharmaceuticals, Inc.2 Celcuity Inc2 Seagen, a wholly owned subsidiary of Pfizer2 London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2 Loxo Oncology, Inc.2 Institut de Recherches Internationales Servier2 Karyopharm Therapeutics Inc2 Corvus Pharmaceuticals, Inc.2 Melanoma and Skin Cancer Trials Limited2 South Australian Health and Medical Research Institute2 Ascentage Pharma Group Inc.2 Australian & New Zealand Children's Haematology/Oncology Group2 Travere Therapeutics, Inc.2 OncoC4, Inc.2 Melanoma Institute Australia2 Exelixis2 Skyhawk Therapeutics, Inc.2 Trans Tasman Radiation Oncology Group2 W.L.Gore & Associates2 Kiora Pharmaceuticals, Inc.2 Verve Therapeutics, Inc.2 Hummingbird Bioscience2 Massachusetts General Hospital2 Kartos Therapeutics, Inc.2 BeiGene2 Eledon Pharmaceuticals2 Suzhou Ribo Life Science Co. Ltd.2 Inhibrx Biosciences, Inc2 NeuShen Therapeutics2 Janssen-Cilag Ltd.2 Aragon Pharmaceuticals, Inc.2 Kite, A Gilead Company2 Australian and New Zealand Intensive Care Research Centre2 Multitude Therapeutics Inc.1 Verastem, Inc.1 Shanghai Argo Biopharmaceutical Co., Ltd.1 Second Life Therapeutics1 Caravel Oculus Pty Ltd1 Rapport Therapeutics Inc.1 Prelude Therapeutics Incorporated1 Ottimo Pharma Limited1 Vaxcyte, Inc.1 Stemline Therapeutics, Inc.1 Damora Therapeutics1 Columbia University1 Turning Point Therapeutics, Inc.1 Servier Bio-Innovation LLC1 University Medical Center Nijmegen1 Cogent Biosciences, Inc.1 Texas Scottish Rite Hospital for Children1 SCBIO Inc.1 MOMA Therapeutics1 TRex Bio, Inc.1 The Florey Institute of Neuroscience and Mental Health1 SAPU NANO (US) LLC1 Biosense Webster, Inc.1 Unity Health Toronto1 McMaster University1 Antengene Biologics Limited1 Spinogenix1 University Medical Center Groningen1 Oticara Australia PTY LTD1 OncoSil Medical Limited1 CSL Behring1 LaNova Medicines Limited1 Shandong Suncadia Medicine Co., Ltd.1 Xencor, Inc.1 Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 Alucent Biomedical1 Colorado Prevention Center1 EBR Systems, Inc.1 Astellas Gene Therapies1 Suzhou Siran Biotechnology Co.,Ltd.1 Supernus Pharmaceuticals, Inc.1 Gain Therapeutics, Inc.1 Sana Biotechnology1 Kyowa Kirin Co., Ltd.1 Alimentiv Inc.1 DePuy International1 Australian and New Zealand Urogenital and Prostate Cancer Trials Group1 Cytokinetics1 Acuity Polymers, Inc.1 Sumitomo Pharma America, Inc.1 Viatris Innovation GmbH1 Medtronic Cardiac Ablation Solutions1 Olivia Newton-John Cancer Research Institute1 GI Innovation, Inc.1 Fondazione Italiana Linfomi - ETS1 Eupraxia Pharmaceuticals Inc.1 Therini Bio Pty Ltd1 DualityBio Inc.1 Brigham and Women's Hospital1 Arovella Therapeutics Ltd1 Western Sydney Local Health District1 Samsung Bioepis Co., Ltd.1 Region Skane1 ICM Co. Ltd.1 Jazz Pharmaceuticals1 Eccogene1 Radiopharm Theranostics, Ltd1 Cellectar Biosciences, Inc.1 Ferronova Pty Ltd1 GPN Vaccines1 University Hospital, Ghent1 Suzhou Suncadia Biopharmaceuticals Co., Ltd.1 V-Wave Ltd1 Janssen Pharmaceutica N.V., Belgium1 Yuhan Corporation1 Sitala Bio LTD1 Epizyme, Inc.1 Rezubio Pharmaceuticals Co., Ltd.1 Fortvita Biologics (USA)Inc.1 University of Wisconsin, Madison1 Ontario Clinical Oncology Group (OCOG)1 Ceryx Medical Australia1 University College, London1 Mirum Pharmaceuticals, Inc.1 Eidos Therapeutics, a BridgeBio company1 Princess Maxima Center for Pediatric Oncology1 BioMarin Pharmaceutical1 NeuHyll AUS Pty Ltd1 Surgical Outcomes Research Centre (SOuRCe)1 Canadian Cancer Trials Group1 Terran Biosciences Australia Pty Ltd1 North Immunology Inc.1 Immunocore Ltd1 Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 McGill University Health Centre/Research Institute of the McGill University Health Centre1 Basking Biosciences, Inc.1 Maia Biotechnology1 Shanghai Junshi Bioscience Co., Ltd.1 Kivu Bioscience Inc.1 Vicore Pharma AB1 Bayer1 Immuneering Corporation1 DBV Technologies1 Altis Medicines, Inc1 Xadcera Biopharmaceutical (Suzhou) Co., Ltd.1 Intellia Therapeutics1 University of Birmingham1 Pierre Fabre Medicament1 Iota Biosciences, Inc1 Arcus Biosciences, Inc.1 Suzhou Biomissile Pharmaceuticals Co., Ltd.1 NRT MedTech Australia Pty Ltd1 Bespoke Clinical Research1 Jiangsu HengRui Medicine Co., Ltd.1 Taiho Pharmaceutical Co., Ltd.1 Neurala Biosciences1 Boston Scientific Corporation1 Adaxion Therapeutics1 Anne Murray1 Gilva Therapeutics Inc.1 Calico Life Sciences LLC1 VDyne, Inc.1 LyncBio Therapeutics Co., Ltd.1 iQure Australia Pty Ltd1 Telethon Kids Institute1 Atridia Pty Ltd.1 Iongen Therapeutics Co., Ltd.1 Pathios Therapeutics Pty Ltd1 University Hospitals of Derby and Burton NHS Foundation Trust1 CRISPR Therapeutics AG1 Ascendis Pharma Oncology Division A/S1 University of South Australia1 NewAmsterdam Pharma1 Imugene Limited1 Sun Pharma Advanced Research Company Limited1 EtiraRx Australia Pty Ltd1 Advanced NanoTherapies1 Biotronik, Inc.1 Haisco Pharmaceutical Group Co., Ltd.1 Clover Biopharmaceuticals AUS Pty1 Iksuda Therapeutics Ltd.1 BicycleTx Limited1 Progentos Therapeutics1 Priovant Therapeutics, Inc.1 Protagonist Therapeutics, Inc.1 Astellas Pharma Global Development, Inc.1 Vidya Therapeutics Inc1 Domain Therapeutics Australia Pty Ltd1 Ionis Pharmaceuticals, Inc.1 University of California, San Francisco1 Syndax Pharmaceuticals1 Donald Mabbott1 Madrigal Pharmaceuticals, Inc.1 Grifols Therapeutics LLC1 ALX Oncology Inc.1 Tafalgie Therapeutics1 Spago Nanomedical AB1 Carina Biotech Limited1 University of Siena1 Vividion Therapeutics, Inc.1 Shanghai Minwei Biotechnology Co., Ltd1 ImmunoVaccine Technologies, Inc. (IMV Inc.)1 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1 Bellus Health Inc. - a GSK company1 ImmVirx Pty Ltd1 Paradigm Biopharmaceuticals Ltd.1 Myeloid Therapeutics1 Cyclarity Therapeutics, Inc.1 Excellergy Inc.1 Shenyang Sunshine Pharmaceutical Co., LTD.1 Toronto Metropolitan University1 Nyrada Pty Ltd1 IDEAYA Biosciences1 InnoVein1 The George Institute1 Jiangsu Hansoh Pharmaceutical Co., Ltd.1 Third Arc Bio1 4D Molecular Therapeutics1 University of Kansas Medical Center1 The Hong Kong Polytechnic University1 Longwood Pharmaceuticals (Hangzhou) Co., Ltd.1 HighLife SAS1 Mission Therapeutics1 Enliven Therapeutics1 Serina Therapeutics1 JointMedica Inc.1 Crinetics Pharmaceuticals Inc.1 MedImmune LLC1 Multitude Therapeutics (Australia) Pty Ltd1 Nested Therapeutics, Inc1 Belite Bio, Inc1 ResMed1 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1 Adcytherix SAS1 Janux Therapeutics1 Pulmonx Corporation1 Eisai Inc.1 Vantage Biosciences Ltd1 Lin BioScience, Inc1 Hanmi Pharmaceutical Company Limited1 Beam Therapeutics Inc.1 Adze Biotechnology Australia Pty Ltd1 Sydney Children's Hospitals Network1 Jubilant Therapeutics Inc.1 Breast Cancer Trials, Australia and New Zealand1 University of Michigan Rogel Cancer Center1 EMD Serono Research & Development Institute, Inc.1 Seismic Therapeutic AU Pty Ltd1 Ipsen1 argenx1 Clear sponsor filter
Target enrolment
to

Trials with a site in Adelaide

5 of 3379 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Active, closed
Pfizer
Phase 3
59
Adelaide, Geelong
2023-08-09
Active, closed
Pfizer
Phase 3
841
Camperdown, Liverpool, St Leonards, Herston, Woolloongabba, Adelaide, Clayton, Heidelberg
2020-12-21
Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
NCT04606446Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
Pfizer
Phase 2
320
Camperdown, Adelaide, Melbourne, Parkville, St Albans, Subiaco
2020-11-16
Active, closed
Pfizer
Phase 3
51
Camperdown, Adelaide, Melbourne, Murdoch, Herston
2019-07-29
Rows per page Showing 1–5 of 5
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 November 2026. https://priyalifescience.com/clinical-trials-australia/city/adelaide

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,379 studies in total at the last sync on 18 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5 of those studies with a site in Adelaide that also match the filters currently applied.

How many clinical trials are recruiting in Adelaide?

2 of the 5 studies on this page are recruiting new participants as of the 18 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Adelaide), 5 studies
PhaseStudiesRecruitingShare
Phase 34180%
Phase 21120%

Most active sponsors

Lead sponsors with the most studies (Adelaide)
Lead sponsorStudiesRecruiting
Pfizer52
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.